- Home
- KSS vs MNKD Comparison
KSS vs MNKD Comparison
Compare KSS & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSS
- MNKD
- Stock Information
- Founded
- KSS 1962
- MNKD 1991
- Country
- KSS United States
- MNKD United States
- Employees
- KSS N/A
- MNKD N/A
- Industry
- KSS Department/Specialty Retail Stores
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- KSS Consumer Discretionary
- MNKD Health Care
- Exchange
- KSS Nasdaq
- MNKD Nasdaq
- Market Cap
- KSS 1.4B
- MNKD 1.6B
- IPO Year
- KSS 1992
- MNKD 2004
- Fundamental
- Price
- KSS $6.48
- MNKD $4.54
- Analyst Decision
- KSS Sell
- MNKD Buy
- Analyst Count
- KSS 12
- MNKD 6
- Target Price
- KSS $10.57
- MNKD $8.92
- AVG Volume (30 Days)
- KSS 14.2M
- MNKD 2.2M
- Earning Date
- KSS 05-29-2025
- MNKD 05-07-2025
- Dividend Yield
- KSS 25.04%
- MNKD N/A
- EPS Growth
- KSS N/A
- MNKD N/A
- EPS
- KSS 0.98
- MNKD 0.10
- Revenue
- KSS $16,221,000,000.00
- MNKD $285,504,000.00
- Revenue This Year
- KSS N/A
- MNKD $14.23
- Revenue Next Year
- KSS N/A
- MNKD $14.56
- P/E Ratio
- KSS $6.61
- MNKD $45.40
- Revenue Growth
- KSS N/A
- MNKD 43.50
- 52 Week Low
- KSS $6.04
- MNKD $3.97
- 52 Week High
- KSS $28.25
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- KSS 37.96
- MNKD 28.12
- Support Level
- KSS $6.04
- MNKD $4.34
- Resistance Level
- KSS $6.96
- MNKD $4.72
- Average True Range (ATR)
- KSS 0.76
- MNKD 0.21
- MACD
- KSS 0.00
- MNKD -0.01
- Stochastic Oscillator
- KSS 16.67
- MNKD 27.03
About KSS Kohl's Corporation
Kohl's operates about 1,176 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 26% of its 2023 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.